Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

4.180 +0.040 (+0.97%)
Streaming Delayed Price Updated: 11:34 AM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
News headline image
1 Artificial Intelligence Stock to Buy Hand Over Fist in October and 1 to Avoid ↗
One of these players could win in AI -- and in the healthcare market, in general. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Is Recursion Pharmaceuticals Stock a Buy Now? ↗
The company has grabbed plenty of headlines recently. 
Via The Motley Fool
News headline image
2 Cathie Wood Stocks I'm Bullish On ↗
These two next-gen biotechs could be outstanding buys for patient investors. 
Via The Motley Fool
News headline image
2 AI Stocks That Aren't Worth the Hype ↗
Even if you're bullish on AI, you may want to think twice about buying shares of these two companies. 
Via The Motley Fool
Topics Artificial Intelligence
Cathie Wood's Ark Invest Sells Nearly $4M Worth Of NVIDIA Shares — Does It Herald Shift To Undervalued AI Gems? ↗
On Monday, Cathie Wood-led Ark Invest made a notable move by selling nearly $4 million worth of NVIDIA Corp (NASDAQ:NVDA) shares. This ... 
Via Benzinga
Topics Artificial Intelligence
News headline image
2 Cathie Wood Stocks That Could Deliver Exponential Returns ↗
These two cutting-edge healthcare companies could be significantly undervalued right now. 
Via The Motley Fool
News headline image
Is Recursion Pharmaceuticals Stock a Buy? ↗
This small-cap stock hopes to revolutionize drug discovery with the help of AI. 
Via The Motley Fool
News headline image
AI Investing: 12 Possible Ways To Maximize Your Returns ↗
It all comes down to playing it smart and doing your research and to help you with that we present 12 micro/small cap AI&R stocks with descriptions of their businesses and their price-to-sales ratios,... 
Via Talk Markets
Topics Artificial Intelligence
News headline image
Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend ↗
Ginkgo Bioworks, Recursion Pharmaceutical, and Eli Lilly are cashing in on the AI-Biotech trend of tomorrow using the big data of today. 
Via InvestorPlace
News headline image
3 Stocks Cathie Wood Is Buying That Should Be on Your List, Too ↗
Cathie Wood is loading up on these healthcare stocks. 
Via The Motley Fool
News headline image
Better Growth Stock: Recursion Pharmaceuticals vs. CRISPR Therapeutics ↗
They're both liable to grow by a lot, but one of them is a safer bet in the near term. 
Via The Motley Fool
News headline image
3 AI Drug Discovery Stocks to Watch ↗
The high cost of developing drugs makes the use of artificial intelligence a natural fit for pharmaceutical companies. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
2 Growth Stocks That Could Rocket 88% to 99% Higher According to Wall Street ↗
Find out why analysts have such high expectations for these stocks. 
Via The Motley Fool
News headline image
AI Integration In Biotech & Pharma: Companies Positioned To Benefit ↗
The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug discovery to patient care.... 
Via Benzinga
Topics Artificial Intelligence
News headline image
Where Will Recursion Pharmaceuticals Be in 3 Years? ↗
This biotech could still be a long way from having a drug on the market in 2026. 
Via The Motley Fool
News headline image
2 Brilliant Growth Stocks With Upsides of About 70%, According to Wall Street ↗
Wall Street analysts foresee these pre-commercial-stage drugmakers rocketing higher over the next 12 months. 
Via The Motley Fool
News headline image
3 Biotech Stocks to Invest In for Big-Time, Long-Term Gains ↗
These biotech stocks to buy and hold offer tremendous upside blending long-term potential with healthcare advances. 
Via InvestorPlace
News headline image
Recursion to Participate in Upcoming Investor Conferences
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection
REC-3964 has been well tolerated in healthy volunteers with no reported serious adverse events. Recursion to explore initiating a Phase 2 proof-of-concept study in patients with recurrent... 
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
Cathie Wood Just Sold Nvidia -- and Bought These 5 Potentially Explosive Growth Stocks Again ↗
The famous growth investor has been making some interesting stock moves lately. 
Via The Motley Fool
News headline image
Better AI Biotech Stock: Recursion Pharmaceuticals vs. 23andMe ↗
Both businesses have a lot to prove. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Cathie Wood's Ark Invest Adjusts Portfolio — Sells Nvidia Shares Worth Nearly $1.9M Amid AI Surge ↗
 
Via Benzinga
Topics Artificial Intelligence
News headline image
Cathie Wood Just Sold Shopify -- and Bought These 7 Potentially Explosive Growth Stocks ↗
The Ark Invest CEO continues to trim Shopify holdings to fund some big purchases. 
Via The Motley Fool
News headline image
3 Clever Tricks to Find Winning Biotech Stocks ↗
You'll need to dig into company details, but the effort is worthwhile. 
Via The Motley Fool
News headline image
AI Bubble Stocks Deflating, Down 14% So Far In August ↗
13 artificial intelligence and related stocks have dramatically outpaced the sector in general since the AI&R bubble began to inflate at the end of April. MTD, however, they have declined 13.6%, on... 
Via Talk Markets
Topics Artificial Intelligence
News headline image
Cathie Wood Mops Up $8.1M Worth Of Zoom Stock After Q2 Earnings Beat, Sells Nvidia Shares In Excess Of $1M ↗
 
Via Benzinga
Topics Earnings
News headline image
Cathie Wood Sells Shopify Shares Worth $9.2M — Ark Goes Shopping This Dutch Payment Company's Stock Instead ↗
 
Via Benzinga
News headline image
Want to Get Rich? 3 Game-Changing Biotech Stocks to Buy Right Now ↗
Biotech stocks may offer some of the most explosive opportunities on the market. Here are three with major catalysts nearing. 
Via InvestorPlace
News headline image
3 Green Flags for Biotech Stocks in 2023 and Beyond ↗
The industry is changing rapidly, and for the better. 
Via The Motley Fool
News headline image
Cathie Wood's Ark Invest Continues To Sell Shopify Shares Amid Q2 Ripples ↗
 
Via Benzinga
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.